China's biotech boom leaves U.S. playing catch-up

axios.com/2025/05/29/china-biotech-boom-us-drug-trials

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new discoveries to American companies.
The big picture: China has become a linchpin in global drug development, the result of a decade-long national strategy to develop a…

This story appeared on axios.com, 2025-05-29 09:30:00.
The Entire Business World on a Single Page. Free to Use →